The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary safety and efficacy of camrelizumab plus nab-paclitaxel and carboplatin as frontline setting in extensive-stage small cell lung cancer (ES-SCLC) from a phase II trial.
 
Shengxiang Ren
No Relationships to Disclose
 
Jia Yu
No Relationships to Disclose
 
Anwen Xiong
No Relationships to Disclose
 
Qi Wang
No Relationships to Disclose
 
Lei Wang
No Relationships to Disclose
 
Bin Chen
No Relationships to Disclose
 
Menghang Yang
No Relationships to Disclose
 
Wei Li
No Relationships to Disclose
 
Jiajia Yuan
No Relationships to Disclose
 
Changhong Zhao
No Relationships to Disclose
 
Caicun Zhou
No Relationships to Disclose